Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma
This study is currently recruiting participants.
Verified January 2013 by H. Lee Moffitt Cancer Center and Research Institute
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborator:
Merck
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT01496807
First received: December 19, 2011
Last updated: January 30, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | February 2016 |
| Estimated Primary Completion Date: | February 2016 (Final data collection date for primary outcome measure) |